Whitehawk Therapeutics, Inc. (WHWK)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

18 annual periodsNewest to oldest
202520242023202220212020201920182017201620152014201320122011201020092008
Revenue$7.1M$26.0M$24.4M$15.2M$14.0M$14.0M$0$20.2M
Research & development$91.0M$51.0M$48.9M$32.7M$19.7M$15.0M$12.8M$17.9M$12.1M$11.4M
Operating expenses$112.3M$17.1M$24.4M$31.3M$21.4M$16.6M
Operating income−$114.4M−$67.5M−$71.9M−$62.7M−$111.2M−$2.5M−$24.4M−$11.2M−$21.4M−$16.6M−$23,006−$23,972−$22,824−$22,391−$23,585−$20,509
EBITDAderived−$114.3M−$67.3M−$71.8M−$62.5M−$111.1M−$2.5M
Net income−$20.6M−$63.7M−$65.8M−$60.5M−$110.1M−$3.5M−$23.3M−$10.4M−$21.4M−$17.0M−$31,440−$30,799−$28,701−$27,365−$27,185−$22,395−$19,996−$33,623
Basic EPSper diluted share-$0.33-$2.36-$2.44-$2.69-$12.41-$1.76-$0.57-$0.31-$1.03-$24.52-$0.01-$0.01-$0.01-$0.01-$0.01$0.00
Diluted EPSper diluted share-$0.33-$2.36-$2.44-$2.69-$12.41-$1.76-$0.57-$0.31-$1.03-$24.52-$0.01-$0.01-$0.01-$0.01-$0.01$0.00

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)24$2.81M disclosed value
24 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Apr 16, 2026Form 4Giacobello Scott M.CHIEF FINANCIAL OFFICERSellCommon Stock141.6K$4.13$584.8K295.2K
Apr 15, 2026Form 4Giacobello Scott M.CHIEF FINANCIAL OFFICERSellCommon Stock77.0K$3.86$297.2K436.8K
Apr 14, 2026Form 4BALL BRYANSee remarksSellCommon Stock92.5K$3.64$336.6K397.1K
Apr 13, 2026Form 4BALL BRYANSee remarksSellCommon Stock26.4K$3.46$91.3K489.6K
Apr 10, 2026Form 4BALL BRYANSee remarksSellCommon Stock6.6K$3.43$22.6K516.0K